INDV · Indivior Pharmaceuticals, Inc.
$39.01
+0.79 (+2.07%)
At close · Aug 14
Market Cap
$4.60B
Shares
118.01M
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-08-03 | Q2 2026 Results and Webcast | Earnings call |
| 2026-08-03 | Proposed Merger of Indivior and Supernus | Event |
| 2026-06-08 | Goldman Sachs 47th Annual Global Healthcare Conference 2026 | Conference |
| 2026-06-03 | 2026 Jefferies Global Healthcare Conference | Conference |
| 2026-04-30 | Q1 2026 Results and Webcast | Earnings call |
| 2026-03-11 | Jefferies “Biotech on the Beach” Summit | Event |
| 2026-02-26 | Q4 / Full Year 2025 Results and Webcast | Earnings call |
| 2025-11-13 | Stifel 2025 Healthcare Conference | Conference |
| 2025-10-30 | Q3 2025 Results | Event |
| 2025-09-08 | Morgan Stanley Global Healthcare Conference | Conference |
| 2025-07-31 | Q2 2025 Results | Event |
Source: https://ir.indivior.com/
Key facts
CIK
1625297
CUSIP
45579U109
13F (30d)
317 filings
316 filers
Visit website
Investor relations